Emerson price target raised to $135 from $128 at Wells Fargo

Wells Fargo analyst Joseph O’Dea raised the firm’s price target on Emerson (EMR) to $135 from $128 and keeps an Overweight rating on the shares. Portfolio news today marks a critical step toward finalizing a multi-year effort in transforming Emerson to pure-play automation, which the firm thinks can drive a re-rating. Wells adds that operational execution in Q4 remained solid and the outlook for 2025 is encouraging.

Published first on TheFly – the ultimate source for real-time, market-movingbreaking financial news Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on EMR:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.